RESPISURE

Pajjiż: New Zealand

Lingwa: Ingliż

Sors: Ministry for Primary Industries

Ixtrih issa

Ingredjent attiv:

mycoplasma hyopneumoniae

Disponibbli minn:

Zoetis New Zealand Limited

INN (Isem Internazzjonali):

mycoplasma hyopneumoniae

Kompożizzjoni:

mycoplasma hyopneumoniae 0 vaccine

Żona terapewtika:

Vaccine

L-istatus ta 'awtorizzazzjoni:

ACVM Registered

Data ta 'l-awtorizzazzjoni:

1994-09-19

Karatteristiċi tal-prodott

                                REGISTRANT:
Zoetis New Zealand Limited, 8 Mahuhu Crescent, Auckland
TRADE NAME:
RespiSure
ACVM NO.:
A006665
PREPARATION DATE:
19 March 2021
PAGE:
1 of 4
BOTTLE LABEL
FRONT PANEL
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
[Pig graphic]
RESPISURE
®
_MYCOPLASMA HYOPNEUMONIAE_ BACTERIN
An aid in the prevention of mycoplasmal pneumonia of pigs caused by
_M. hyopneumoniae. _
50 Dose
100 mL
[Zoetis logo]
BOTTLE LABEL
SIDE PANEL
DIRECTIONS: Vaccination of all swine on the premises is recommended to
enhance herd
immunity. See enclosed leaflet for complete directions and
precautions.
PRECAUTIONS: Store at 2 to 8°C (Refrigerate). Do NOT freeze. Unused
vaccine must be
discarded within 10 hours of opening. If anaphylaxis occurs following
use, administer adrenaline or
equivalent.
RVM
Registered pursuant to the ACVM Act 1997 No. A6665
See www.foodsafety.govt.nz for registration conditions
Made in the USA
[Zoetis logo]
Zoetis New Zealand Ltd
8 Mahuhu Crescent, Auckland
Technical Services 0800 650 277
® Registered Trademark
[Label identifier]
[Barcode]
Ser:
Exp:
REGISTRANT:
Zoetis New Zealand Limited, 8 Mahuhu Crescent, Auckland
TRADE NAME:
RespiSure
ACVM NO.:
A006665
PREPARATION DATE:
19 March 2021
PAGE:
2 of 4
BOTTLE LABEL – EXTENDED FORMAT - INSERT
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
[Pig graphic]
RESPISURE
®
_MYCOPLASMA HYOPNEUMONIAE _BACTERIN_ _
PRODUCT DESCRIPTION: RespiSure is a bacterin for vaccination of
healthy swine as an aid in
the prevention of chronic pneumonia caused by _Mycoplasma
hyopneumoniae_. RespiSure contains
chemically inactivated whole cell culture of _M. hyopneumoniae,
_coupled with a unique oil adjuvant_, _
Amphigen

, to enhance and prolong the immune response without causing
detectable tissue
damage at the injection site.
DISEASE DESCRIPTION: Mycoplasmal pneumonia of swine (MPS), or enzootic
pneumonia, is a
widespread, chronic disease characterised by coughing, growth
retardation, and reduced feed
ef
                                
                                Aqra d-dokument sħiħ
                                
                            

Fittex twissijiet relatati ma 'dan il-prodott

Ara l-istorja tad-dokumenti